LeaderPortfolio
Hamied
Yusuf Hamied
Rank #1769
INDIAHealthcarePharmaceuticals

Yusuf Hamied

Net Worth
$2.358B
0% (24h)
Yusuf Khwaja Hamied, born in 1936, is an Indian scientist and billionaire businessman, most recognized as the non-executive chairman of Cipla, a leading pharmaceutical company. His career has been marked by his commitment to providing affordable healthcare, particularly in developing countries, by defying large pharmaceutical companies to offer generic drugs. With a net worth estimated at $2.5 billion as of 2024, he has received numerous awards, including the Padma Bhushan. Hamied's contributions extend beyond business, as he has supported education and healthcare initiatives.

The Full Dossier

Early Life

Yusuf Hamied was born on July 25, 1936, in Vilnius, Lithuania (then Poland). He was raised in Bombay (now Mumbai). His father, Khwaja Abdul Hamied, was an Indian Muslim, and his mother, Luba Derczanska, was a Russophone Lithuanian Jewish. He attended the Cathedral and John Connon School and St. Xavier's College in Mumbai before pursuing higher education in England.

Rise to Success

Hamied earned a BA in chemistry in 1957 and a PhD from Christ's College, Cambridge. He joined Cipla, founded by his father, and took over as chairman in 1989. His career is characterized by his efforts to make life-saving medications, especially for HIV/AIDS and other ailments, accessible to people in developing countries. He is known for providing affordable generic drugs, challenging the practices of large Western pharmaceutical companies. This earned him both recognition and controversy within the industry.

Key Business Strategies

Hamied pioneered the development of affordable, multi-drug combination pills for HIV/AIDS, tuberculosis, and asthma. His strategies involved expanding the production of bulk drugs and active pharmaceutical ingredients in India, thereby reducing costs and increasing access to medicine. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

Philanthropy

Hamied has been involved in several philanthropic initiatives. He has supported educational causes and contributed to healthcare facilities. He has made major donations to Cambridge University's chemistry department, including the foundation of the Hamied Scholars Programme. He also contributed to the IISER Pune for a state-of-the-art chemistry facility.

Career Timeline

1989

Chairman of Cipla

Became the Chairman of Cipla, continuing to lead the company's mission of providing affordable healthcare.

1976

Managing Director of Cipla

Became the Managing Director of Cipla.

1960

Joined Cipla

Joined the family business as a research officer after completing his PhD.

Philanthropic Impact

Education$0.02B

IISER Pune Chemistry Facility

Donated to IISER Pune for a state-of-the-art chemistry facility to be used in outreach programs.

EducationUnknown

Hamied Scholars Programme

Supported Cambridge University's chemistry department, leading to the foundation of the Hamied Scholars Programme.

Wealth Trajectory